Does CETUXIMAB Cause Hyperammonaemia? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Hyperammonaemia have been filed in association with CETUXIMAB (ERBITUX). This represents 0.1% of all adverse event reports for CETUXIMAB.
8
Reports of Hyperammonaemia with CETUXIMAB
0.1%
of all CETUXIMAB reports
2
Deaths
4
Hospitalizations
How Dangerous Is Hyperammonaemia From CETUXIMAB?
Of the 8 reports, 2 (25.0%) resulted in death, 4 (50.0%) required hospitalization.
Is Hyperammonaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CETUXIMAB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does CETUXIMAB Cause?
Off label use (1,549)
Rash (883)
Diarrhoea (874)
Neutropenia (744)
Nausea (663)
Malignant neoplasm progression (662)
Dyspnoea (542)
Decreased appetite (541)
Vomiting (533)
Death (518)
What Other Drugs Cause Hyperammonaemia?
VALPROIC ACID (581)
VALPROATE (328)
FLUOROURACIL (263)
DIVALPROEX (256)
LEVETIRACETAM (192)
TACROLIMUS (181)
ACETAMINOPHEN (177)
OXALIPLATIN (160)
TOPIRAMATE (156)
GLYCEROL PHENYLBUTYRATE (147)
Which CETUXIMAB Alternatives Have Lower Hyperammonaemia Risk?
CETUXIMAB vs CETYLPYRIDINIUM
CETUXIMAB vs CEVIMELINE
CETUXIMAB vs CHAMPIX
CETUXIMAB vs CHANTIX
CETUXIMAB vs CHENODIOL